Publications Trends in end-of-life (EOL) systemic oncologic treatment in contemporary clinical practice: insights from real-world data September 24, 2021 Canavan, M, Wang, X, Ascha, MS, Miksad, RA, Showalter, TN, Calip, GS, Gross, CP. ASCO Quality Care Symposium. . https://ascopubs.org/doi/abs/10.1200/JCO.2020.39.28_suppl.253 Authors:Canavan, M, Wang, X, Ascha, MS, Miksad, RA, Showalter, TN, Calip, GS, Gross, CP Sources:ASCO Quality Care Symposium Read the research SharePosted inTreatment and Testing patterns More publicationsOctober 2026Treatment patterns and survival outcomes in a real-world cohort of lutetium 177 vipivotide tetraxetan-experienced patients with metastatic castration-resistant prostate cancerMay 2026Real-world treatment patterns and outcomes among patients with high-risk and very high-risk non-metastatic prostate cancerMay 2026Real-world second-line treatment patterns and outcomes by platinum sensitivity in extensive-stage small cell lung cancer in the post-immunotherapy era
October 2026Treatment patterns and survival outcomes in a real-world cohort of lutetium 177 vipivotide tetraxetan-experienced patients with metastatic castration-resistant prostate cancer
May 2026Real-world treatment patterns and outcomes among patients with high-risk and very high-risk non-metastatic prostate cancer
May 2026Real-world second-line treatment patterns and outcomes by platinum sensitivity in extensive-stage small cell lung cancer in the post-immunotherapy era